S-767-119
Read twice and referred to the Committee on the Judiciary.
Sponsored by Mark Kelly (D-AZ)
What it does
The bill would amend the 1998 Office of National Drug Control Policy law to authorize $333,000,000 for each of fiscal years 2025 through 2030 for the High Intensity Drug Trafficking Areas (HIDTA) program. It would require a report on HIDTA funds used against fentanyl trafficking, including seizures, prosecutions and regional threat data, and would require reports on limits a HIDTA faces in meeting its goals. It would raise a dollar figure in subsection (s) from $10,000,000 to $14,224,000, add fentanyl interdiction assistance as a purpose, and let the Director add other fentanyl-related purposes. It would also require the Attorney General to make available sufficient prosecution resources as practicable, including temporary reassignment of assistant U.S. attorneys who prioritize fentanyl cases, and to set up a request process within 180 days.
Who benefits
Federal, state, local and Tribal law enforcement agencies that take part in HIDTA task forces and could receive funding and interdiction assistance. Communities affected by fentanyl trafficking, if the added enforcement reduces supply. Congress and the public, who would get more reporting on seizures, prosecutions and program limits. Federal prosecutors' offices in HIDTA regions that may get reassigned attorneys for fentanyl cases.
Who is hurt
Federal taxpayers, who would bear the authorized $333 million per year, about $2 billion over six years, if it is appropriated. U.S. Attorney's offices that may lose assistant U.S. attorneys to temporary reassignment, and their non-fentanyl caseloads. Individuals and organizations investigated or prosecuted for fentanyl trafficking, who may face more enforcement. HIDTA coordinators and participating agencies that would take on added reporting work. Other federal priorities that compete for the same appropriations.
Supporters argue
Supporters argue that fentanyl is a leading driver of overdose deaths and that HIDTA already coordinates federal, state, local and Tribal agencies across jurisdictions. They contend that a stated funding level, required seizure and prosecution reports, and dedicated prosecutors would improve results and accountability, and note the bill's bipartisan sponsorship.
Opponents argue
Opponents argue that decades of supply-focused enforcement have not ended overdose deaths and that a six-year authorization of about $2 billion favors enforcement over treatment and prevention. They contend that pulling assistant U.S. attorneys toward fentanyl cases may strain other prosecutions, and that the broad discretion for the Director to add purposes weakens congressional oversight.
Constitutional context
The bill rests on Congress's spending power and its authority to regulate interstate drug trafficking under the Commerce Clause (Gonzales v. Raich, 2005). It raises no distinct constitutional question, though enforcement under it remains subject to Fourth Amendment limits on searches and seizures.
Checks and balances
The executive branch (ONDCP Director and Attorney General) gains funding authority and prosecutorial reassignment power, while Congress keeps checks through annual appropriations and the new reporting requirements.
Historical precedent
Congress has repeatedly reauthorized HIDTA since creating it in 1988 and reauthorized it in the 1998 and 2006 ONDCP reauthorization acts.